Patients and Providers Benefit
PhySoft AMS™ provides benefits to ESRD patients and dialysis providers alike. Patients will experience improved outcomes and a heightened sense of well-being. Dialysis services providers will realize organizational benefits from the deployment of advanced, intuitive technology, which will also help them reduce expenses and regain some of their ever-shrinking margin.
Clinical Benefits of PhySoft AMS ™
-
Clinicians will be able to set unique Hgb target levels for each individual patient, reach and maintain those goals, significantly improving patient outcomes. The majority of patients may be systematically managed, enabling clinicians to focus on acute cases
-
Hemoglobin variability or cycling will be greatly reduced, providing an improved patient quality of life and sense of well-being.
-
Model accuracy enables clinicians to use Hgb excursions as a catalyst to search for inter-current illness or other issues affecting the patient’s ability to respond to ESAs. PhySoft AMS™ offers a ‘patient condition dashboard’ display of anemia–related factors and trends that enables clinicians to monitor and manage each patient’s unique response.
-
PhySoft AMS™ enables clinicians to practice individualized medicine, using the patient’s physiologic parameters to simulate the patient’s Hgb-response to ESAs, and provide the optimum dosing regimen to attain the clinician’s chosen Hgb-target level for that patient.
-
PhySoft AMS™ provides the platform from which quality-of-life discussions may take place between clinician and patient. It is a simple process to precisely change Hgb-target levels to determine the exact Hgb-level at which the patient’s sense of well-being is in balance with the level of risk he or she is willing to accept in the form of higher ESA dosages. It provides clinicians with the ability to fine tune the ESA dosage to meet the patient’s QoL needs.
Organizational Benefits from PhySoft AMS
-
The technology provides the mechanism to easily centralize or decentralize the management of anemia to match the organizational requirements of the dialysis services provider. Mayo Clinic utilized one Anemia Manager to track and manage hundreds of patients distributed across several locations of its dialysis network. Conversely, other organizations will use the product to decentralize the Anemia Management function. They will utilize PhySoft AMS™ to standardize treatment in multiple facilities, while shifting the responsibility to locally based Nurse Practioners. The SaaS delivery of the service makes it practical to have clinicians from any geographic location provide anemia management to patients in any network facility. There is no impact on IT infrastructure for the organization or its facilities. Physicians and clinicians need only an Internet connection to access PhySoft AMS™.
-
PhySoft AMS™ provides anytime, anywhere access – clinicians may access a patient’s dashboard and supporting functions from their office, the facility or bedside.
-
PhySoft AMS™ streamlines the management of anemia so that Anemia Managers may significantly expand the patient population for which they have responsibility, while improving care.
-
PhySoft AMS™ is the mechanism through which implementation and timely adoption of an organization’s changes in dosing standards may be affected. It acts as tool for standardization. Mayo Clinic was able to react to ESA labeling changes and revised CMS guidelines almost immediately, rewriting prescriptions and utilizing new ESA dosages for over 350 patients in less than 2-days.
-
Dialysis services providers' ESA usage and inventory requirements become much more predictable, making ordering and budgeting easier to manage.
-
PhySoft AMS™ will make it easier to attain and manage QIP goals.
-
Dialysis services providers' adoption of PhySoft AMS™ technology is not dependent upon up-to-date IT infrastructure. This cutting-edge technology is accessible and affordable to any sized provider.
Financial Benefits Derived from PhySoft AMS
-
ESA usage will be significantly reduced, well beyond the labeling-driven changes of a few years ago. PhySoft AMS™ maintains patients at their target Hgb-level using the lowest required dosage. This will help dialysis services providers maintain margin, even as changes to the CMS Bundle jeopardizes potential profit.
-
PhySoft AMS™ has been shown to reduce the number of hospitalizations for a patient and also reduce the length of stay. The benefit to a dialysis services provider is the regaining of as many as three lost dialysis sessions per patient, per year. The benefit to an integrated provider is the avoidance of the typical under reimbursement from CMS for hospital stays.
-
PhySoft AMS™ will help protect margins for dialysis services providers because of optimal dosing recommendations, using the minimum dosage required.